Hypertension in adults: diagnosis and management
KEYWORDS: blood, pressure, blood pressure, people, treatment, hypertension, committee, evidence, recommendations, cardiovascular, recommendation, disease, guideline, step, diabetes

preference to an ACE inhibitor, in addition to step 1 treatment. [2019] Step 3 treatment 1.4.44 Before considering next step treatment for hypertension: • review the person's medications to ensure they are being taken at the optimal tolerated doses and • discuss adherence (see recommendation 1.4.40). [2019] 1.4.45 If hypertension is not controlled in adults taking step 2 treatment, offer a combination of: • an ACE inhibitor or ARB (see also recommendation 1.4.30 for people of Black African or African–Caribbean family origin) and • a CCB and • a thiazide-like diuretic. [2019] For a short explanation of why the committee made the 2019 recommendations and how they might affect practice, see the rationale and impact section on step 2 and 3 treatment. Full details of the evidence and the committee's discussion are in evidence review F: step 2 and step 3 treatment. Step 4 treatment 1.4.46 If hypertension is not controlled in adults taking the optimal tolerated doses of an ACE inhibitor or an ARB plus a CCB and a thiazide-like diuretic, regard them as having resistant hypertension. [2019] 1.4.47 Before considering further treatment for a person with resistant hypertension: • Confirm elevated clinic blood pressure measurements using ambulatory or
